Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01618721 · ClinicalTrials.gov registry record
Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)
A clinical trial, sponsored by Echosense.
- Terminated
- Registry status
- 200
- Enrollment target
NCT01618721: Clinical Trial study, sponsored by Echosense.
NCT01618721 is a clinical trial that was terminated before completion, run by Echosense. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01618721 was terminated before completion, sponsored by Echosense.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The study seeks to characterize data obtained from patients with a variety of lung diseases using ultrasound Doppler signals obtained from lung tissue. A standard ultrasound device in a Doppler mode is placed on the chest wall and the unique software the investigators have developed analyzes the signals reflected from within the lung. On the basis of of pilot studies performed previously the investigators expect to receive different signals from different diseases that will enable diagnosis of different lung diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-12 |
Why NCT01618721 stopped before completion
NCT01618721 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01618721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01618721 about?
NCT01618721 is a clinical study titled "Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)". The study seeks to characterize data obtained from patients with a variety of lung diseases using ultrasound Doppler signals obtained from lung tissue. A standard ultrasound device in a Doppler mode is placed on the chest wall and the unique software the investigators have developed analyzes the sig...
What is the current status of trial NCT01618721?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2011-12.
Who is sponsoring clinical trial NCT01618721?
This trial is sponsored by Echosense, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia